Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2012/09/002948
CTRI/2012/09/002948
Completed
Phase 4

Safety and Effectiveness of Dexmedetomidine for sedation during awake nasal fibreoptic intubation ? A prospective, randomized, double blind study

Kasturba Hospital KMC Manipal0 sites36 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Scheduled for awake nasal fibreoptic intubation in view of assessed difficult airway

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Scheduled for awake nasal fibreoptic intubation in view of assessed difficult airway
Sponsor
Kasturba Hospital KMC Manipal
Enrollment
36
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Kasturba Hospital KMC Manipal

Eligibility Criteria

Inclusion Criteria

  • •All patients between 18\-85 years undergoing awake nasal fibreoptic intubation

Exclusion Criteria

  • •ASA physical status IV
  • •Raised intracranial pressure
  • •Uncontrolled seizure disorder and/or known psychiatric illness
  • •Current (in the past 14 days) treatment with an α2 agonist or antagonist
  • •Patients in whom dexmedetomidine or benzodiazepine administration is contra\-indicated
  • •Patients with acute unstable angina, laboratory confirmed acute myocardial infarction within the past 6 weeks, heart rate \< 50 bpm, systolic blood pressure (SBP) \< 90 mmHg, or complete heart block unless they have a pacemaker
  • •Patients with elevated SGPT (ALT) and/or SGOT (AST) values of \> 2 times the upper limit of normal.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Patient safety and satisfaction with dexmedetomidine sedation during endoscopic oesophageal interventions
ISRCTN68599804Academic Medical Centre (AMC) (Netherlands)64
Completed
Phase 3
Safety and Effectiveness using DEXmedetomidine sedation versus Propofol/Alfentanil sedation during oesophagus interventions. (SEDEX)
NL-OMON35831Academisch Medisch Centrum64
Not yet recruiting
Not Applicable
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgery
CTRI/2024/07/070582Dr Sridevi Mulimani
Completed
Not Applicable
To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTPHealth Condition 1: null- FEMALE PATIENTS SCHEDULED FOR LAPAROSCOPIC TUBAL LIGATION WITH MEDICAL TERMINATION OF PREGNANCY
CTRI/2017/11/010353ALL INDIA INSTITUTE OF MEDICAL SCIENCES80
Active, not recruiting
Phase 1
EFFECTIVENESS OF INTRANASAL DEXMEDETOMIDINE FOR SEDATEDAUDITORY BRAINSTEM RESPONSE TESTINGChild requiring auditory evaluation in a context of suspicion of deafness, language delay, overall developmental delay, risk factors for hearing loss.MedDRA version: 20.1Level: PTClassification code 10049507Term: Brain stem auditory evoked responseSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
EUCTR2018-001466-42-FRFondation Lenval - Hôpitaux Pédiatriques de Nice CHULENVA60